Author Question: Treatment of the infant with persistent pulmonary hypertension may include which of the fol-lowing? ... (Read 41 times)

skymedlock

  • Hero Member
  • *****
  • Posts: 561
Treatment of the infant with persistent pulmonary hypertension may include which of the fol-lowing? 1. ECMO 2. High-frequency ventilation 3. Nitric oxide 4. Caffeine citrate
 
  a. 1 and 3 only
  b. 1, 2, and 3 only
  c. 3 and 4 only
  d. 2, 3, and 4 only

Question 2

Treatment of the premature infant with apnea includes which of the following? a. Tactile stimulation b. Caffeine citrate c. Transfusion d. Manage underlying cause
 
  a. 1 and 3 only
  b. 1, 2, and 4 only
  c. 3 and 4 only
  d. 1, 2, 3, and 4



LegendaryAnswers

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

ANS: B
Initial therapy for PPHN is removal of the underlying cause, such as administration of oxygen for hypoxemia, surfactant for RDS, glucose for hypoglycemia, and inotropic agents for low cardiac output and systemic hypotension. If correction of the underlying problem does not correct the hypoxemia, the infant needs intubation and mechanical ventilation. Because pain and anxiety may contribute to PPHN, the infant may need sedation and, frequently, paralysis. If these measures do not improve oxygenation, the next step is HFV. This mode of ventilation allows a higher FRC without a large tidal volume. Inhaled nitric oxide is now considered the next inter-vention. Should all of these modalities fail to improve oxygenation, the infant may be a candi-date for extracorporeal membrane oxygenation (ECMO).

Answer to Question 2

ANS: D
Table 34-3 outlines current treatment strategies for infants with apnea.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

Eat fiber! A diet high in fiber can help lower cholesterol levels by as much as 10%.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

For a complete list of videos, visit our video library